rs1805087
badMag 3.5This is a variant in the MTR gene that changes a aspartate to an glycine.
Key Literature Trait Associations
Methionine Synthase / B12 Metabolism
The MTR A2756G variant (rs1805087) is a missense polymorphism (Asp919Gly) in methionine synthase, the vitamin B12-dependent enzyme that remethylates homocysteine to methionine. The G allele may increase enzyme activity, leading to faster depletion of methylcobalamin (active B12). Combined with MTHFR C677T, this variant can contribute to persistently elevated homocysteine unless treated with both B12 and folate.
Coronary heart disease
A meta-analysis of 23 case-control studies found the MTR A2756G GG homozygous genotype is associated with increased coronary heart disease risk in Europeans (OR=1.63, 95% CI 1.18–2.25, p=0.001), while the heterozygous genotype showed a smaller, non-significant trend. The association is primarily observed in European-ancestry populations and is thought to be mediated through modest elevation of plasma homocysteine. A smaller Indian cohort study (n=435) corroborated this direction (OR=1.48, 95% CI 1.09–2.00). The overall effect is modest and the MTRR A66G interaction further amplifies cardiovascular risk.
Prostate cancer
A meta-analysis pooling 12 case-control studies (9,986 cases, 40,134 controls) found the MTR rs1805087 G allele is associated with modestly increased prostate cancer risk (G vs. A OR=1.14, 95% CI 1.02–1.28). In white males specifically, the GA heterozygous genotype showed OR=1.19 (95% CI 1.01–1.40) versus AA homozygotes. Subgroup analyses were consistent across hospital-based and population-based controls. The biological mechanism is thought to involve altered methionine availability affecting DNA methylation patterns in prostate tissue. The effect size is modest and requires replication in larger consortia.
Breast cancer
A meta-analysis of 92 genetic association studies found the MTR rs1805087 G allele is associated with elevated breast cancer risk in Caucasian and East Asian women, though not in South Asians. The analysis concluded that rs1805087 can help identify individuals at higher breast cancer risk, alongside MTRR rs1801394 and MTHFR rs1801133. The effect is ancestry-specific and likely reflects differences in folate pathway gene–environment interactions across populations. Overall effect sizes were not individually reportable from the available abstract, warranting caution in clinical interpretation.
Neural tube defects
Multiple meta-analyses have evaluated the MTR A2756G polymorphism in relation to neural tube defect (NTD) risk and produced largely null results in isolation. A 2013 PLoS One meta-analysis of 9 studies (843 NTD cases, 1,006 controls) found no significant association across dominant, recessive, or allelic models. However, an important exception emerges in gene–gene interactions: infants carrying mutant alleles at both MTR A2756G and MTRR A66G showed a dramatically elevated NTD risk (OR=5.1, 95% CI 1.7–15.4), suggesting this variant acts as a modifier rather than an independent NTD risk factor. The evidence for standalone risk remains low.
▶ClinVar annotation
Disorders of Intracellular Cobalamin Metabolism; Gastrointestinal stromal tumor; MTR-related disorder; Methylcobalamin deficiency type cblG (HMAG); Neural tube defects, folate-sensitive, susceptibility to; not specified
View on ClinVar →▶Research that mentions this SNP (14)
▶Association of main folate metabolic pathway gene polymorphisms with neural tube defects in Han population of Northern ChinaAssociationN=321Yulian Fang et al.(2018)· Child's Nervous System
A case-control study of 152 NTD patients and 169 controls in Han Chinese population identified three folate metabolism pathway SNPs associated with neural tube defects: rs2236225 in MTHFD1 (allele A, OR=1.500; AA genotype OR=2.862), rs1801133 in MTHFR (allele T, OR=1.552; TT genotype OR=2.344), and rs1801394 in MTRR (allele G, OR=1.533; GG genotype OR=2.355). The study demonstrates genetic variation in folate metabolism significantly affects NTD susceptibility.
▶Focused screening of a panel of cancer‐related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemiaAssociationN=1,495Sonja Offenmüller et al.(2014)· Pediatric Blood & Cancer
A candidate gene association study screening 1,421 SNPs in 407 cancer-related genes identified two novel susceptibility loci for childhood B-precursor acute lymphoblastic leukemia: rs6966 in PPP1R13L/ERCC2 region (OR=3.74, 95% CI 2.31-6.04, p=4.55×10⁻⁹) and rs414580 in MSR1 (OR=3.93, 95% CI 2.31-6.69, p=6.09×10⁻⁸). A third SNP, rs11762213 in MET, showed borderline significance (p=2.97×10⁻²).
▶MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or without cleft palate in the Brazilian populationAssociationN=1,712Sibele Nascimento de Aquino et al.(2014)· Birth Defects Research Part A: Clinical and Molecular Teratology
Case-control study of 501 young stroke patients and 1,211 controls examining 58 polymorphisms in 17 genes involved in methionine metabolism. Multiple logistic regression identified four independent risk factors for early-onset ischaemic stroke: rs10037045 BHMT (OR 1.38, p=0.033), rs682985 BHMT2 (OR 1.46, p=0.017), rs1051319 CBS (OR 3.75, p<0.0001), and rs202680 FOLH1 (OR 3.00, p<0.0001). Haplotype analyses identified significant associations with BHMT, CBS, FOLH1, MTR, PON2, TCN2 and TYMS haplotypes and stroke risk.
▶Folate and vitamin B12-related genes and risk for omphaloceleAssociationN=930James L. Mills et al.(2012)· Human Genetics
Case-control study of 169 omphalocele cases and 761 controls examining variants in folate, vitamin B12, and homocysteine metabolism genes. Variants in transcobalamin receptor (TCblR) rs2232775 (Q8R) and methylenetetrahydrofolate reductase (MTHFR) rs1801131 (1298A>C) were significantly associated with omphalocele (TCblR OR=3.20, p=0.0017; MTHFR OR=2.04, p=0.028). Additional race-ethnicity-specific associations were found with TCN2, BHMT rs3733890, and FOLH1 variants, suggesting disruption of methylation reactions as a potential risk factor.
▶Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myelomaAssociationN=237Niels F. Andersen et al.(2012)· International Journal of Cancer
This case-control association study examined genetic polymorphisms in 237 Russian women to identify variants associated with early reproductive loss and recurrent miscarriage. The study found that DNMT3B rs2424913 (OR=4.44-4.78), DNMT1 rs2228611 (OR=3.0-3.94), and DNMT1 rs8101626 (OR=2.5-3.1) were significantly associated with increased risk of sporadic and recurrent early pregnancy loss, while SYCP3 rs769825641 heterozygotes showed elevated risk of sporadic miscarriage.
▶Genetic Predictors of Response to Photodynamic TherapyReviewFrancesco Parmeggiani et al.(2011)· Molecular Diagnosis & Therapy
Comprehensive review evaluating SNPs as genetic predictors of choroidal neovascularization (CNV) response to photodynamic therapy with verteporfin (PDT-V). The paper examines pharmacogenetic correlations for thrombo-coagulative pathway variants (MTHFR rs1801133, F5 rs6025, F2 rs1799963, F13A1 rs5985), complement/inflammatory variants (CFH, HTRA1, CRP, ARMS2), and VEGFA variants (rs699947, rs2146323), concluding that specific SNPs show clinical plausibility as markers to optimize PDT-V efficacy and guide therapeutic approaches in neovascular macular degeneration.
▶Folate pathway and nonsyndromic cleft lip and palateAssociationN=445Susan H. Blanton et al.(2011)· Birth Defects Research Part A: Clinical and Molecular Teratology
This family-based association study examined 14 folate pathway genes using 89 SNPs in 445 NSCLP families (317 non-Hispanic White, 128 Hispanic) to identify genetic variants contributing to nonsyndromic cleft lip and palate. Evidence for association was found with SNPs in NOS3 and TYMS in the non-Hispanic White group (rs2373929/NOS3, rs502396/TYMS, and others), and with MTR, BHMT2, MTHFS, and SLC19A1 in the Hispanic group (rs1422086/BHMT2, rs2115540/MTHFS significant after Bonferroni correction). Multiple gene-gene interactions were detected, with CBS and MTHFD1 showing the most extensive interactions. Significant interactions were also found between several SNPs and maternal smoking and one SNP (rs651646/FOLR2) with offspring sex.
▶Polymorphisms in CHDH gene and the risk of tooth agenesisAssociationN=344Adrianna Mostowska et al.(2011)· Birth Defects Research Part A: Clinical and Molecular Teratology
This case-control study examined 21 SNPs in 13 folate and choline metabolism genes for associations with tooth agenesis (hypodontia/oligodontia) in a Polish population of 159 cases and 185 controls. The CHDH gene variant rs6445606 showed the strongest association with a protective effect (OR=0.434, p=0.0004), with individuals carrying the C allele having reduced risk of tooth agenesis. Multifactor dimensionality reduction analysis revealed a significant epistatic interaction between CHDH rs6445606 and PLD2 rs3764897 (p=0.004).
▶Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study populationAssociationN=2,079Tonia C. Carter et al.(2011)· American Journal of Medical Genetics Part A
This case-control and family-based study evaluated 64 SNPs in 34 genes for associations with spina bifida in 558 Irish case-families and 994 controls. Spina bifida was significantly associated with LEPR rs1805134 (GRR: 1.5, P = 0.0264) and COMT rs737865 (GRR: 1.4, P = 0.0206), with additional confirmations of previous findings in MTHFR 677C>T and other genes, suggesting roles for leptin signaling and methylation pathways in neural tube defect pathogenesis.
▶Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndromeAssociationN=243Adam E. Locke et al.(2010)· Genetic Epidemiology
This case-control study examined folate pathway gene variants in 121 DS-AVSD cases and 122 DS controls (no CHD). Tag SNPs in MTHFR, MTR, MTRR, CBS, and SLC19A1 were genotyped. SLC19A1 showed significant gene-level association with atrioventricular septal defect (P=0.01), with multiple tag SNPs nominally associated (OR 1.08-1.72). All significant SLC19A1 SNPs showed strong LD (r²≥0.80) with the nonsynonymous variant rs1051266 (c.80A>G, p.H27R). MTHFR c.1298A was over-transmitted to cases (P=0.05) and under-transmitted to controls (P=0.02), showing association in FBAT analysis (P=0.03 dominant, P=0.01 additive). These results suggest folate pathway disruption contributes to AVSD risk in Down syndrome individuals.
▶Genetic variants in one‐carbon metabolism‐related genes contribute to NSCLC prognosis in a Chinese populationAssociationN=564Guangfu Jin et al.(2010)· Cancer
This association study screened 57 SNPs from 11 one-carbon metabolism genes in 564 NSCLC patients to identify genetic variants affecting lung cancer prognosis. Key findings included favorable prognostic associations for MTR rs3768160 A>G (HR=0.78, 95% CI 0.62-0.98), MTRR rs2966952 G>A (HR=0.84, 95% CI 0.71-0.99), and DHFR rs1650697 G>A (HR=0.83, 95% CI 0.70-0.99), with unfavorable prognosis for MTHFD1 rs1950902 G>A (HR=1.18, 95% CI 0.99-1.40). Combined analysis of these four SNPs demonstrated a locus-dosage effect on NSCLC survival (P trend = 6.9×10⁻⁵) and identified combined genotypes as an independent prognostic factor.
▶Endothelin‐1 gene polymorphism and hearing impairment in elderly JapaneseAssociationN=5,167Yasue Uchida et al.(2009)· The Laryngoscope
This longitudinal study of 5,167 Japanese community-dwelling adults (aged 40-84 years) examined the association between MTHFR C677T (rs1801133) and MTR A2756G (rs1805087) polymorphisms and age-related hearing impairment. The MTHFR 677T allele was significantly associated with reduced hearing impairment risk (OR: 0.7609, 95% CI: 0.6178-0.9372) only in individuals with MTR AA genotype. The favorable effect of the MTHFR 677T allele was independent of folate and homocysteine levels, while elevated homocysteine was independently associated with increased hearing impairment risk.
▶Folate metabolism genes, vegetable intake and renal cancer risk in central EuropeAssociationN=2,652Moore LE et al.(2008)· International Journal of Cancer
A case-control study of 1,097 renal cell carcinoma (RCC) cases and 1,555 controls in Central and Eastern Europe examined common genetic variation in 5 folate metabolism genes. Variants in MTHFR (A222V rs1801133) and TYMS (IVS2-405C rs502396) were significantly associated with RCC risk, with the MTHFR variant increasing risk (OR=1.44) particularly in groups with low vegetable intake, while TYMS variant reduced risk (OR=0.73). The associations demonstrated significant gene-nutrient interactions with vegetable consumption.
▶Folate and one‐carbon metabolism gene polymorphisms and their associations with oral facial cleftsAssociationN=553Abee L. Boyles et al.(2008)· American Journal of Medical Genetics Part A
This family-based association study examined 12 polymorphisms in one-carbon metabolism genes (BHMT, CBS, MTHFD1, MTHFR, MTR, MTRR, SLC19A1, TCN2) and their associations with oral facial clefts in 553 Norwegian families. CBS rs234706 showed a significant maternal protective effect on cleft lip/palate risk (LRT p=0.008), with homozygous carriers of the T allele showing reduced risk (RR=0.50, 95% CI 0.26-0.96). MTHFR rs1801133 demonstrated a protective effect in the low-folate supplementation subset (RR=0.60-0.44), and maternal folic acid supplementation ≥400 μg/day was associated with 39% reduction in cleft lip/palate risk.
Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…